Option Health Ltd Dba Bioscrip Infusio Elmhurst, IL - 60126

Option Health Ltd Dba Bioscrip Infusio is categorized under Health Services in Elmhurst, IL and active since 2012.

Option Health Ltd Dba Bioscrip Infusio was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.

If you are seeking more information, feel free to contact James P Melancon at the company’s single location by writing to 321 West Lake St # G, Elmhurst, Illinois IL 60126 or by phoning (952) 979-3680. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Option Health Ltd Dba Bioscrip Infusio
Contact Person: James P Melancon
Address: 321 West Lake St # G, Elmhurst, Illinois 60126
Phone Number: (952) 979-3680
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 621999
Share This Business:

Option Health Ltd Dba Bioscrip Infusio was started in 2012 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact James P Melancon for inquiries that concern Option Health Ltd Dba Bioscrip Infusio by calling the company number (952) 979-3680, as your correspondence is most welcome. Additionally, the physical location of the single location of Option Health Ltd Dba Bioscrip Infusio can be found at the coordinates 41.918353,-87.949116 as well as the street address 321 West Lake St # G in Elmhurst, Illinois 60126.

For its online presence, you may visit Option Health Ltd Dba Bioscrip Infusio’s website at and engage with its social media outlets through on Twitter and on Facebook.